Literature DB >> 1317391

MR imaging of extracranial nerve sheath tumors.

D G Varma1, A Moulopoulos, A S Sara, N Leeds, R Kumar, E E Kim, S Wallace.   

Abstract

We retrospectively reviewed MR images of 32 histologically proven extracranial nerve sheath tumors (NSTs). There were 23 benign (10 neurofibromas, 13 schwannomas) and 9 malignant NSTs. On T1-weighted images (T1WIs) tumors were isointense or slightly hyperintense to muscle. On T2-weighted images (T2WIs) (11 lesions) and enhanced T1WIs (1 intraspinal lesion), a target pattern with peripheral hyperintense rim and central low intensity was seen in 12 of 23 (52%) benign NSTs (5 of 10 neurofibromas and 7 of 13 schwannomas). This pattern corresponded histologically to peripheral myxomatous tissue and central fibrocollagenous tissue. The pattern was absent in lesions with cystic, hemorrhagic, or necrotic degeneration. These tumors were hyperintense and variably inhomogenous on T2WIs. Malignant NSTs were hyperintense and variably inhomogenous on T2WIs and mimicked benign variably inhomogeneous lesions unless involvement of contiguous structures was visualized. A target pattern was not visible in malignant lesions. Magnetic resonance imaging cannot distinguish schwannomas from neurofibromas, and benign tumors may mimic malignant NSTs when cystic, hemorrhagic, and necrotic degeneration is present. A target pattern may be visualized in some benign NSTs, and evaluation of this sign with assessment of location and growth along nerves may help to avoid confusion with other lesions.

Entities:  

Mesh:

Year:  1992        PMID: 1317391     DOI: 10.1097/00004728-199205000-00020

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  15 in total

1.  Imaging findings of neurogenic tumours in the head and neck region.

Authors:  Y N Kami; T Chikui; K Okamura; Y Kubota; K Oobu; H Yabuuchi; E Nakayama; K Hashimoto; K Yoshiura
Journal:  Dentomaxillofac Radiol       Date:  2011-11-10       Impact factor: 2.419

2.  Plexiform schwannoma of the forearm.

Authors:  Keiichi Katsumi; Akira Ogose; Tetsuo Hotta; Hiroshi Hatano; Hiroyuki Kawashima; Hajime Umezu; Naoto Endo
Journal:  Skeletal Radiol       Date:  2003-10-31       Impact factor: 2.199

Review 3.  Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns.

Authors:  F J Wippold; M Lubner; R J Perrin; M Lämmle; A Perry
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

Review 4.  Plexopathy.

Authors:  B C Bowen; D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-02       Impact factor: 3.825

5.  Benign schwannoma masquerading as a malignant metastatic lesion in a patient with renal cell carcinoma.

Authors:  Santhosh Sadashiv; Georgios Deftereos; Eli Pakravan; Jan F Silverman; Shifeng Mao
Journal:  Gastrointest Cancer Res       Date:  2014-05

6.  Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging.

Authors:  Kenichiro Hamada; Takafumi Ueda; Ichiro Higuchi; Atsuo Inoue; Noriyuki Tamai; Akira Myoi; Yasuhiko Tomita; Katsuyuki Aozasa; Hideki Yoshikawa; Jun Hatazawa
Journal:  Skeletal Radiol       Date:  2004-10-09       Impact factor: 2.199

Review 7.  Imaging tumours of the brachial plexus.

Authors:  Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2003-03-20       Impact factor: 2.199

8.  Benign extracranial nerve sheath tumors of the skull base: postoperative morbidity and management.

Authors:  Deb Biswas; Conor Marnane; Ranjit Mal; David Baldwin
Journal:  Skull Base       Date:  2008-03

9.  Schwannomas of the upper extremity: diagnosis and treatment.

Authors:  Roberto Adani; Alessio Baccarani; Enrico Guidi; Luigi Tarallo
Journal:  Chir Organi Mov       Date:  2008-07-08

10.  Spontaneous hip dislocation secondary to intraarticular neurofibroma: a case report.

Authors:  Rajendra Kumar; Afranio dos Reis Teixeira Neto; Michael T Deavers; Behrang Amini; Valerae O Lewis
Journal:  Skeletal Radiol       Date:  2014-02-04       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.